These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31150773)

  • 1. Rapidly dissolving bilayer microneedle arrays - A minimally invasive transdermal drug delivery system for vitamin B12.
    Ramöller IK; Tekko IA; McCarthy HO; Donnelly RF
    Int J Pharm; 2019 Jul; 566():299-306. PubMed ID: 31150773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.
    González-Vázquez P; Larrañeta E; McCrudden MTC; Jarrahian C; Rein-Weston A; Quintanar-Solares M; Zehrung D; McCarthy H; Courtenay AJ; Donnelly RF
    J Control Release; 2017 Nov; 265():30-40. PubMed ID: 28754611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.
    McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF
    J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery.
    Pamornpathomkul B; Ngawhirunpat T; Tekko IA; Vora L; McCarthy HO; Donnelly RF
    Eur J Pharm Sci; 2018 Aug; 121():200-209. PubMed ID: 29777854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
    Shah V; Choudhury BK
    AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
    Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
    Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, optimization, and evaluation for a long-time-released transdermal microneedle delivery system containing estradiol.
    Tang X; Qin H; Zhang X; Yang H; Yang J; Chen P; Jin Y; Yang L
    Drug Deliv Transl Res; 2024 Jun; 14(6):1551-1566. PubMed ID: 38062287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays.
    Garland MJ; Migalska K; Tuan-Mahmood TM; Raghu Raj Singh T; Majithija R; Caffarel-Salvador E; McCrudden CM; McCarthy HO; David Woolfson A; Donnelly RF
    Int J Pharm; 2012 Sep; 434(1-2):80-9. PubMed ID: 22669101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolving microneedle based transdermal delivery of therapeutic peptide analogues.
    Dillon C; Hughes H; O'Reilly NJ; Allender CJ; Barrow DA; McLoughlin P
    Int J Pharm; 2019 Jun; 565():9-19. PubMed ID: 31047995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
    Garland MJ; Caffarel-Salvador E; Migalska K; Woolfson AD; Donnelly RF
    J Control Release; 2012 Apr; 159(1):52-9. PubMed ID: 22265694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing intradermal delivery of tofacitinib citrate: Comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays.
    Cárcamo-Martínez Á; Mallon B; Anjani QK; Domínguez-Robles J; Utomo E; Vora LK; Tekko IA; Larrañeta E; Donnelly RF
    Int J Pharm; 2021 Jan; 593():120152. PubMed ID: 33301867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
    Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
    Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogel-forming microneedle arrays: Potential for use in minimally-invasive lithium monitoring.
    Eltayib E; Brady AJ; Caffarel-Salvador E; Gonzalez-Vazquez P; Zaid Alkilani A; McCarthy HO; McElnay JC; Donnelly RF
    Eur J Pharm Biopharm; 2016 May; 102():123-31. PubMed ID: 26969262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
    Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
    Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery.
    Courtenay AJ; McAlister E; McCrudden MTC; Vora L; Steiner L; Levin G; Levy-Nissenbaum E; Shterman N; Kearney MC; McCarthy HO; Donnelly RF
    J Control Release; 2020 Jun; 322():177-186. PubMed ID: 32200001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
    McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
    J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.
    Migalska K; Morrow DI; Garland MJ; Thakur R; Woolfson AD; Donnelly RF
    Pharm Res; 2011 Aug; 28(8):1919-30. PubMed ID: 21437789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.